The global point-of-care testing market report contains an in-depth profiling of the key market players, along with the recent developments (New product launches, partnerships, agreements, collaborations, and joint ventures) and strategies adopted by them to sustain and strengthen their positions in the market.
Pune, India -- (SBWIRE) -- 04/17/2018 -- Global Point of Care Testing Market is expected to reach USD 35.3 billion by 2024 from USD 18.6 billion in 2016, growing at a CAGR of 8.4% in the forecast period 2017 to 2024. The new market report contains data for historic year 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024.
To request a free sample copy or view summary of this report, click the link below @ http://databridgemarketresearch.com/request-a-sample/?dbmr=point-care-testing-poct-market
Market Segmentation:
Global Point-of-care Testing (POCT) Market By Product (Blood Glucose Testing Kits, Cardiometabolic Monitoring Kits, Infectious Disease Testing Kits, Cholesterol Testing Kits, Pregnancy & Fertility Tests Kits, Tumor/Cancer Markers, Urinalysis Testing Kits, Cholesterol Test Strips, Hematology Testing Kits, Drugs Of Abuse Testing Kits, Fecal Occult Testing Kits, Rapid Coagulation Testing Kits, & Others),By Prescription Mode (Prescription Based Testing & Over-The-Counter Testing),By Distribution Channel (Direct Tenders & Retail),By End User (Hospital, Clinics, Ambulatory Care, Home Healthcare, & Research Laboratory), By Geography (North America, Europe, Asia-Pacific, South America, Rest of the World) – Trends and Forecast to 2024.
Market Big Players:
The global point-of-care market is highly concentrated to a few big players and rest to local players who cater to domestic markets only. F. Hoffmann-La Roche Ltd dominated the point-of-care market accounting for a highest market share in 2016, followed by Siemens AG and Abbott. Other players in this market include Beckman Coulter, Inc., Becton, Dickinson and Company, Johnson & Johnson, Alere Inc., Instrumentation Laboratory, PTS Diagnostics, Abaxis, Inc., Medtronic, Accriva Diagnostics, OPTI Medical, Sienco, Inc., Alpha Scientific, AccuBioTech Co., Ltd., ACON Laboratories, Inc., Acrongenomics, Inc, bioMérieux SA, Biomerica, Inc., Atlas Genetics Ltd., Alfa Scientific Designs, Inc., Bio-Rad Laboratories, Inc., Medica Corporation, and Nova Biomedica among others holds 53.1% of the global injectable drug delivery market in 2016.
Any specific requirements are you looking for? Ask to your Industry Experts @ http://databridgemarketresearch.com/inquire-before-buying/?dbmr=point-care-testing-poct-market
HOFFMANN-LA ROCHE LTD:
Historical Background – Roche was established in 1896
Nature of Business: F. Hoffmann-La Roche Ltd., is one of the largest biotech company with 17 biopharmaceuticals on the market. The company is operating in more than 100 countries around the globe. Some of the subsidiaries are Genetech, Roche Diagnostics, Chugai Pharmaceutical Co., Ventana Medical Systems, InterMune, Inc., Syntex, Anadys Pharmaceuticals, Roche Applied Science, Bioveris, Roche products, Inc., Roche pharma AG, Pt Roche Indonesia, Bina Technologies, Inc., nv Roche sa, Roche SAS, Roche Glycart AG, Roche Co., Ltd.
Main focus: Since the establishment in 1896, the company's main focus is on oncology, immunology, ophthalmology, infectious diseases and neuroscience.
Main Business Areas: Pharmaceuticals and Diagnostics.
Recent Developments:
1. In August 2016,Roche Diagnostics Ltd., received FDA approval for cobas Influenza A/B & RSV test for the cobasLiat System that differentiates flu and Respiratory Syncytial Virus (RSV) in 20 minutes
2. In May 2015, Roche Diagnostics Ltd., received FDA CLIA Waiver for the cobasLiat PCR System and Strep A assay to test Strep A in throat swab specimen.
3. In December 2014, Roche Diagnostics Ltd, received FDA approval for LightMix Ebola Zaire rRT-PCR Test at the time of emergency to treat Ebola Zaire virus infection.
Looking for more insights from this report? click the link below @ http://databridgemarketresearch.com/reports/point-care-testing-poct-market/
Market Drivers:
Some of the major factors driving the market for Point-Of-Care Testing Market, such as increasing geriatric population, increase in infectious diseases (hepatitis, HIV infection, influenza, respiratory infections and others), technological advancements, introduction of home-based point of care devices, and rapid economic development in the emerging economies. These factors such as increased awareness among the population, ease of use, rapid test, right dosage to the right place, and enhanced patient compliance are also driving the growth for the point-of-care testing market.
Growing Geriatric Population : Global Point-of-Care Testing Market
Improved economic growth, better healthcare, and growthin access to education have led to longer life expectancy in most socio-economic groups. Due to growing geriatric population, the cases of acute and chronic diseases are rising. Older population is more prone to diseases such as diabetes, infections, cardiometabolic risks and cancer. The normal aging process causes a variety of physical and emotional issues that can be difficult for both the geriatric patient and healthcare worker to understand their needs and be sensitive in their treatment
Advancement In Technology : Global Point-of-Care Testing Market
POCT technologies are evolving, and this market segment is growing at a rapid pace. The use of POCT has evolved further since 2013, with high range of professional and self-monitoring tests into the ambulatory setting with a patient centric focus.. The need to improve patient safety and outcomes through rapid testing with trustworthy and actionable results at the point of care has provided significant benefits, including the ability to provide immediate and appropriate medical intervention. A continuous effort and progress has been made by manufacturers to create products with newer, advanced technologies with reduced sample volume or less blood on portable devices
Decentralized Laboratory Testing : Global Point-of-Care Testing Market
For decentralized lab testing, there are two drivers i.e., need for better drug monitoring for diseases like cancer and increasing virulence of infectious diseases. Molecular testing for hospital acquired infections has risen over the last several years so as to reduce cost and length of stay (LOS). Most of the molecular diagnostic tests are carried out in large reference lab or in CLIA-accredited labs but due to more availability of molecular diagnostic tests (specifically for conditions giving a quick result) decentralized labs ora push towards decentralized testing and near-patient settings are seen as a feasible and growing market
Questions? We'll Put You On The Right Path Request Analyst Call for Global Point-of-Care Testing (POCT) Market Report Visit @ http://databridgemarketresearch.com/speak-to-analyst/?dbmr=point-care-testing-poct-market
TABLE OF CONTENTS GLOBAL POINT-OF-CARE TESTING MARKET
1. INTRODUCTION
1.1. OBJECTIVES OF THE STUDY
1.2. MARKET DEFINITION
1.3. OVERVIEW OF GLOBAL POINT-OF-CARE TESTING MARKET
1.4. CURRENCY AND PRICING
1.5. LIMITATION
1.6. MARKETS COVERED
2. MARKET SEGMENTATION
2.1. MARKETS COVERED
2.2. GEOGRAPHIC SCOPE
2.3. YEARS CONSIDERED FOR THE STUDY
2.4. CURRENCY AND PRICING
2.5. RESEARCH METHODOLOGY
2.6. PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.7. SECONDARY SOURC
2.8. ASSUMPTIONS
3. MARKET OVERVIEW
3.1. DRIVERS
3.1.1. GROWING GERIATRIC POPULATION
3.1.2. ADVANCEMENT IN TECHNOLOGY
3.1.3. DECENTRALIZED LABORATORY TESTING
3.1.4. INCREASED INCIDENCE OF CHRONIC DISEASES
3.1.5. LABORATORY STAFF SHORTAGES
3.2. RESTRAINTS
3.2.1. UNFAVOURABLE REIMBURSEMENT SCENARIO
3.2.2. ECONOMIC COST
3.3. OPPORTUNITIES
3.3.1. EMERGING MICROFLUIDIC LAB-ON-A-CHIP TECHNOLOGY
3.3.2. EMERGING MARKETS
3.3.3. UNMET MEDICAL NEEDS
3.4. CHALLENGES
3.4.1. LACK OF ACCURACY AND EFFICIENCY
3.4.2. DATA MANAGEMENT AND LACK OF CONNECTIVITY
3.4.3. TESTING PERFORMED BY NON-LABORATORY PERSONNEL AND LACK OF AWARENESS AMONG THE USERS
4. EXECUTIVE SUMMARY
5. PREMIUM INSIGHTS
6. GLOBAL POINT-OF-CARE TESTING MARKET: REGULATORY SCENARIO
6.1. OVERVIEW:
6.1.1. REGULATORY PROCEDURE:
7. GLOBAL POINT-OF-CARE TESTING MARKET: REIMBURSEMENT SCENARIO
7.1. OVERVIEW:
8. GLOBAL POINT-OF-CARE TESTING MARKET, BY PRODUCT TYPE
8.1. OVERVIEW
8.2. CARDIOMETABOLIC MONITORING KITS
8.2.1. CARDIAC MARKERS
8.2.2. BLOOD GAS ELECTROLYTE TESTING KITS
8.2.3. HBA1C TESTING KITS
8.2.4. LIPID TESTING KITS
8.3. INFECTIOUS DISEASE TESTING KITS
8.3.1. INFLUENZA TESTING KITS
8.3.2. HIV TESTING KITS
8.3.3. HEPATITIS TESTING KITS
8.3.4. STD TESTING KITS
8.3.5. TROPICAL DISEASESTESTING KITS
8.3.6. HEALTHCARE ASSOCIATED TESTING KITS
8.3.7. RESPIRATORY INFECTIONS TESTING KITS
8.4. CHOLESTEROL TESTING KITS
8.4.1. PROTHROMBIN TIME TESTING KITS
8.4.2. ACTIVATED CLOTTING TIME TESTING KITS
8.5. BLOOD GLUCOSE TESTING KITS
8.6. PREGNANCY AND FERTILITY TESTING KITS
8.7. TUMOR CANCER MARKERS
8.8. URINALYSIS TESTING KITS
8.9. HEMATOLOGY TESTING KITS
8.10. DRUGS OF ABUSE TESTING KITS
8.11. FECAL OCCULT TESTING KITS
8.12. RAPID COAGULATION TESTING KITS
9. GLOBAL POINT-OF-CARE TESTING MARKET, BY DISTRIBUTION CHANNEL
9.1. OVERVIEW
9.1.1. DIRECT TENDER
9.1.2. RETAIL PHARMACY
10. GLOBAL POINT-OF-CARE TESTING MARKET, BY END USER
10.1. OVERVIEW
10.2. GLOBAL POCT MARKET: HOSPITALS
10.3. GLOBAL POCT MARKET: CLINICS
10.4. GLOBAL POCT MARKET: AMBULATORY CARE
10.5. GLOBAL POCT MARKET: HOME HEALTHCARE
10.6. GLOBAL POCT MARKET: RESEARCH LABORATORIES
11. GLOBAL POINT-OF-CARE TESTING MARKET, BY PRESCRIPTION MODE
11.1. OVERVIEW
11.2. GLOBAL POCT MARKET: PRESCRIPTION BASED TESTING KITS
11.3. GLOBAL POCT MARKET: OVER THE COUNTER BASED TESTING KITS
12. GLOBAL POINT-OF-CARE TESTING MARKET, BY GEOGRAPHY
12.1. OVERVIEW
12.2. NORTH AMERICA POINT-OF-CARE TESTING MARKET
12.2.1. U.S.POINT-OF-CARE TESTING MARKET
12.2.2. CANADA POINT-OF-CARE TESTING MARKET
12.2.3. MEXICO POINT-OF-CARE TESTING MARKET
12.3. EUROPE POINT-OF-CARE TESTING MARKET
12.3.1. GERMANY POINT-OF-CARE TESTING MARKET
12.3.2. FRANCE POINT-OF-CARE TESTING MARKET
12.3.3. U.K. POINT-OF-CARE TESTING MARKET
12.3.4. ITALY POINT-OF-CARE TESTING MARKET
12.3.5. SPAIN POINT-OF-CARE TESTING MARKET
12.3.6. RUSSIA POINT-OF-CARE TESTING MARKET
12.3.7. TURKEY POINT-OF-CARE TESTING MARKET
12.3.8. BELGIUM POINT-OF-CARE TESTING MARKET
12.3.9. NETHERLANDS POINT-OF-CARE TESTING MARKET
12.3.10. SWITZERLAND POINT-OF-CARE TESTING MARKET
12.3.11. REST OF EUROPE POINT-OF-CARE TESTING MARKET
12.4. APAC POINT-OF-CARE TESTING MARKET
12.4.1. JAPAN POINT-OF-CARE TESTING MARKET
12.4.2. CHINA POINT-OF-CARE TESTING MARKET
12.4.3. SOUTH KOREA POINT-OF-CARE TESTING MARKET
12.4.4. INDIA POINT-OF-CARE TESTING MARKET
12.4.5. AUSTRALIA POINT-OF-CARE TESTING MARKET
12.4.6. SINGAPORE POINT-OF-CARE TESTING MARKET
12.4.7. THAILAND POINT-OF-CARE TESTING MARKET
12.4.8. MALAYSIA POINT-OF-CARE TESTING MARKET
12.4.9. INDONESIA POINT-OF-CARE TESTING MARKET
12.4.10. PHILIPPINES POINT-OF-CARE TESTING MARKET
12.4.11. REST OF APAC POINT-OF-CARE TESTING MARKET
12.5. MEA POINT-OF-CARE TESTING MARKET
12.5.1. SOUTH AFRICA POINT-OF-CARE TESTING MARKET
12.5.2. SAUDI ARABIA POINT-OF-CARE TESTING MARKET
12.5.3. UAE POINT-OF-CARE TESTING MARKET
12.5.4. REST OF MEA POINT-OF-CARE TESTING MARKET
12.6. SOUTH AMERICA POINT-OF-CARE TESTING MARKET
12.6.1. BRAZIL POINT-OF-CARE TESTING MARKET
13. GLOBAL POINT-OF-CARE TESTING MARKET : COMPANY LANDSCAPE
13.1. COMPANY SHARE ANALYSIS: GLOBAL
13.2. COMPANY SHARE ANALYSIS: NORTH AMERICA
13.3. COMPANY SHARE ANALYSIS: EUROPE
13.4. COMPANY SHARE ANALYSIS: APAC
14. COMPANY PROFILES
14.1. JOHNSON AND JOHNSON SERVICES, INC.
14.2. BECTON, DICKINSON AND COMPANY
14.3. MEDTRONIC
14.4. F. HOFFMANN-LA ROCHE LTD
14.5. SIEMENS AG
14.6. ABBOTT
14.7. DANAHER
14.8. WERFENLIFE
14.9. HENRY SCHEIN, INC.
14.10. OPTI MEDICAL (SUBSIDIARY OF IDEXX LABORATORIES, INC)
14.11. SIENCO, INC.
14.12. ACON LABORATORIES, INC.
14.13. ATIVA MEDICAL CORPORATION
14.14. ABAXIS
14.15. ARKRAY, INC
14.16. AERSCHER DIAGNOSTICS, LLC
14.17. ARTRON LABORATORIES, INC.
14.18. BIOMERIEUX SA
14.19. ENTOPSIS
15. RELATED REPORTS
Browse Detailed TOC, Tables and Figures @ http://databridgemarketresearch.com/toc/?dbmr=point-care-testing-poct-market
Related Report
Europe POCT Device Market – Trends and Forecast To 2024
Europe Point-of-care Testing (POCT) Market, By Product (Blood Glucose Testing Kits, Cardiometabolic Monitoring Kits, Infectious Disease Testing Kits, Cholesterol Testing Kits, Pregnancy & Fertility Tests Kits, Tumor/Cancer Markers, Urinalysis Testing Kits, Cholesterol Test Strips, Hematology Testing Kits, Drugs Of Abuse Testing Kits, Fecal Occult Testing Kits, Rapid Coagulation Testing Kits), Prescription Mode (Prescription, OTC), Distribution Channel, End User, Country – Trends and Forecast to 2024
Report Access: http://databridgemarketresearch.com/reports/europe-poct-device-market/
About Data Bridge Market Research
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavours to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.
Contact:
Vishal Dixit
Data Bridge Market Research
Tel: +1-888-387-2818
Email: sopan.gedam@databridgemarketresearch.com